These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9305866

  • 1. Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin 1.
    Francisco JA, Gawlak SL, Siegall CB.
    J Biol Chem; 1997 Sep 26; 272(39):24165-9. PubMed ID: 9305866
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen.
    Francisco JA, Gilliland LK, Stebbins MR, Norris NA, Ledbetter JA, Siegall CB.
    Cancer Res; 1995 Jul 15; 55(14):3099-104. PubMed ID: 7541711
    [Abstract] [Full Text] [Related]

  • 4. Single-chain immunotoxins targeted to CD40 for the treatment of human B-lineage hematologic malignancies.
    Francisco JA, Siegall CB.
    Leuk Lymphoma; 1998 Jul 15; 30(3-4):237-45. PubMed ID: 9713956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates.
    Siegall CB, Gawlak SL, Chace D, Wolff EA, Mixan B, Marquardt H.
    Bioconjug Chem; 1994 Jul 15; 5(5):423-9. PubMed ID: 7849072
    [Abstract] [Full Text] [Related]

  • 7. Cytokine activation sensitizes human monocytic and endothelial cells to the cytotoxic effects of an anti-CD40 immunotoxin.
    Francisco JA, Kiener PA, Moran-Davis P, Ledbetter JA, Siegall CB.
    J Immunol; 1996 Aug 15; 157(4):1652-8. PubMed ID: 8759752
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.
    Rosenblum MG, Cheung LH, Liu Y, Marks JW.
    Cancer Res; 2003 Jul 15; 63(14):3995-4002. PubMed ID: 12873997
    [Abstract] [Full Text] [Related]

  • 12. Construction and characterization of human CD7-specific single-chain Fv immunotoxins.
    Pauza ME, Doumbia SO, Pennell CA.
    J Immunol; 1997 Apr 01; 158(7):3259-69. PubMed ID: 9120282
    [Abstract] [Full Text] [Related]

  • 13. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
    Thompson J, Stavrou S, Weetall M, Hexham JM, Digan ME, Wang Z, Woo JH, Yu Y, Mathias A, Liu YY, Ma S, Gordienko I, Lake P, Neville DM.
    Protein Eng; 2001 Dec 01; 14(12):1035-41. PubMed ID: 11809934
    [Abstract] [Full Text] [Related]

  • 14. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.
    Stirpe F, Wawrzynczak EJ, Brown AN, Knyba RE, Watson GJ, Barbieri L, Thorpe PE.
    Br J Cancer; 1988 Nov 01; 58(5):558-61. PubMed ID: 3265330
    [Abstract] [Full Text] [Related]

  • 15. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 01; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 16. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
    Zewe M, Rybak SM, Dübel S, Coy JF, Welschof M, Newton DL, Little M.
    Immunotechnology; 1997 Jun 01; 3(2):127-36. PubMed ID: 9237097
    [Abstract] [Full Text] [Related]

  • 17. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells.
    Friedman PN, McAndrew SJ, Gawlak SL, Chace D, Trail PA, Brown JP, Siegall CB.
    Cancer Res; 1993 Jan 15; 53(2):334-9. PubMed ID: 8417827
    [Abstract] [Full Text] [Related]

  • 18. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
    Dunn RD, Weston KM, Longhurst TJ, Lilley GG, Rivett DE, Hudson PJ, Raison RL.
    Immunotechnology; 1996 Sep 15; 2(3):229-40. PubMed ID: 9373315
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
    Bolognesi A, Tazzari PL, Olivieri F, Polito L, Lemoli R, Terenzi A, Pasqualucci L, Falini B, Stirpe F.
    Br J Haematol; 1998 Apr 15; 101(1):179-88. PubMed ID: 9576199
    [Abstract] [Full Text] [Related]

  • 20. Anti-CD30 immunotoxins with native and recombinant dianthin 30.
    Bolognesi A, Tazzari PL, Legname G, Olivieri F, Modena D, Conte R, Stirpe F.
    Cancer Immunol Immunother; 1995 Feb 15; 40(2):109-14. PubMed ID: 7882380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.